---
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/275393236.md"
description: "The Hang Seng Biotechnology Index rose over 4% intraday, CSPC PHARMA rose over 7%, INNOVENT BIO rose nearly 7%, WUXI BIO and SINO BIOPHARM rose over 5%"
datetime: "2026-02-10T02:43:33.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/275393236.md)
  - [en](https://longbridge.com/en/news/275393236.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/275393236.md)
---

# 

The Hang Seng Biotechnology Index rose over 4% intraday, CSPC PHARMA rose over 7%, INNOVENT BIO rose nearly 7%, and WUXI BIO and SINO BIOPHARM rose over 5%

### Related Stocks

- [01093.HK](https://longbridge.com/en/quote/01093.HK.md)
- [01801.HK](https://longbridge.com/en/quote/01801.HK.md)
- [02269.HK](https://longbridge.com/en/quote/02269.HK.md)
- [08189.HK](https://longbridge.com/en/quote/08189.HK.md)
- [01177.HK](https://longbridge.com/en/quote/01177.HK.md)
- [08037.HK](https://longbridge.com/en/quote/08037.HK.md)
- [02509.HK](https://longbridge.com/en/quote/02509.HK.md)

## Related News & Research

- [Sino Biopharm Showcases Promising Obesity Antibody Data and Expands Weight-Loss Pipeline](https://longbridge.com/en/news/286328735.md)
- [CICC Sticks to Their Buy Rating for Innovent Biologics (IVBXF)](https://longbridge.com/en/news/285050005.md)
- [GSK and SBP Group team up to advance bepirovirsen launch in China](https://longbridge.com/en/news/286073604.md)
- [Sino Biopharm Advances First-in-Class CCR8 Antibody Into Phase III Gastric Cancer Trial](https://longbridge.com/en/news/285458913.md)
- [Sino Biopharm Sets Hybrid AGM, Seeks Fresh Share Issue Mandate](https://longbridge.com/en/news/284532331.md)